SCHEMBL25466151

SCHEMBL25466151

CC(=O)OC(c1ccccc1)c1ccccc1C(OC(C)=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
CYP3A4 P08684 1/20 0.53
PABPC1 P11940 1/20 0.45
APOBEC3A P31941 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
TSHR P16473 1/20 0.45
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.41
IDO1 P14902 2/20 0.41
TDO2 P48775 2/20 0.41
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
SRC P12931 1/20 0.40
GLS O94925 2/20 0.40
HCAR2 Q8TDS4 1/20 0.40
IDO2 Q6ZQW0 1/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1202828 0.90 ALDH1A1 (0.58) ALDH1A1CYP3A4PABPC1APOBEC3AAPOBEC3G
SCHEMBL276079 0.89 PTGS2 (0.49) ALDH1A1CYP3A4ESR1ESR2
SCHEMBL13083237 0.86 ALDH1A1 (0.45) ALDH1A1CYP3A4PABPC1APOBEC3AAPOBEC3G
Hydrazine SCHEMBL18138498 0.86 ALDH1A1 (0.55) ALDH1A1CYP3A4PABPC1APOBEC3AAPOBEC3G
SCHEMBL16002841 0.85 ALDH1A1 (0.49) ALDH1A1CYP3A4PABPC1APOBEC3AAPOBEC3G
SCHEMBL10627201 0.82 FAAH (0.55)
SCHEMBL6895354 0.82 ALDH1A1 (0.52) ALDH1A1CYP3A4TSHRKMT2AHSD17B10
SCHEMBL11130696 0.79 ALDH1A1 (0.49) ALDH1A1CYP3A4PABPC1APOBEC3AAPOBEC3G
Bromide SCHEMBL10735522 0.78 ALDH1A1 (0.47) ALDH1A1CYP3A4PABPC1APOBEC3AAPOBEC3G
SCHEMBL28647416 0.78 ALDH1A1 (0.41) ALDH1A1CYP3A4PABPC1APOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143961-A1 NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143961-A1 NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY2, TRPA1, ANXA1 ALDH1A1 12/4885CYP3A4 132/4885PABPC1 2556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.